216 related articles for article (PubMed ID: 17044060)
1. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.
Kim SW; Kim JW; Kim YT; Kim JH; Kim S; Yoon BS; Nam EJ; Kim HY
Genes Chromosomes Cancer; 2007 Jan; 46(1):1-9. PubMed ID: 17044060
[TBL] [Abstract][Full Text] [Related]
2. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.
Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR
Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747
[TBL] [Abstract][Full Text] [Related]
4. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.
Katoh H; Shibata T; Kokubu A; Ojima H; Loukopoulos P; Kanai Y; Kosuge T; Fukayama M; Kondo T; Sakamoto M; Hosoda F; Ohki M; Imoto I; Inazawa J; Hirohashi S
J Hepatol; 2005 Nov; 43(5):863-74. PubMed ID: 16139920
[TBL] [Abstract][Full Text] [Related]
5. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
[TBL] [Abstract][Full Text] [Related]
6. High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas.
Diosdado B; Buffart TE; Watkins R; Carvalho B; Ylstra B; Tijssen M; Bolijn AS; Lewis F; Maude K; Verbeke C; Nagtegaal ID; Grabsch H; Mulder CJ; Quirke P; Howdle P; Meijer GA
Clin Cancer Res; 2010 Mar; 16(5):1391-401. PubMed ID: 20179237
[TBL] [Abstract][Full Text] [Related]
7. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
[TBL] [Abstract][Full Text] [Related]
8. Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.
Kudoh K; Takano M; Koshikawa T; Hirai M; Yoshida S; Mano Y; Yamamoto K; Ishii K; Kita T; Kikuchi Y; Nagata I; Miwa M; Uchida K
Clin Cancer Res; 1999 Sep; 5(9):2526-31. PubMed ID: 10499629
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O
Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658
[TBL] [Abstract][Full Text] [Related]
10. High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells.
Prasad M; Bernardini M; Tsalenko A; Marrano P; Paderova J; Lee CH; Ben-Dor A; Barrett MT; Squire JA
Genes Chromosomes Cancer; 2008 May; 47(5):427-36. PubMed ID: 18273836
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of drug resistance in human ovarian carcinoma studied by comparative genomic hybridization].
Ying HC; Zhang SL; Jiang T; Ouyang L; Lü J
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1009-12. PubMed ID: 17672960
[TBL] [Abstract][Full Text] [Related]
13. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
Ching HC; Naidu R; Seong MK; Har YC; Taib NA
Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
[TBL] [Abstract][Full Text] [Related]
15. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas.
Meza-Zepeda LA; Kresse SH; Barragan-Polania AH; Bjerkehagen B; Ohnstad HO; Namløs HM; Wang J; Kristiansen BE; Myklebost O
Cancer Res; 2006 Sep; 66(18):8984-93. PubMed ID: 16982739
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
[TBL] [Abstract][Full Text] [Related]
17. Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma.
Hidalgo A; Baudis M; Petersen I; Arreola H; Piña P; Vázquez-Ortiz G; Hernández D; González J; Lazos M; López R; Pérez C; García J; Vázquez K; Alatorre B; Salcedo M
BMC Cancer; 2005 Jul; 5():77. PubMed ID: 16004614
[TBL] [Abstract][Full Text] [Related]
18. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization.
Wolf NG; Abdul-Karim FW; Farver C; Schröck E; du Manoir S; Schwartz S
Genes Chromosomes Cancer; 1999 Aug; 25(4):307-15. PubMed ID: 10398423
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
[TBL] [Abstract][Full Text] [Related]
20. Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients.
Sung JS; Park KH; Kim YH
Cancer Genet Cytogenet; 2010 Apr; 198(1):27-34. PubMed ID: 20303011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
